高分子バイオアナリシス試験サービスの北米、欧州、アジア太平洋市場、予測（～2030年）

北米、欧州、アジア太平洋の高分子バイオアナリシス試験サービス市場は、ハイテクで信頼性の高い高分子バイオアナリシス試験サービスに対する需要の向上、臨床試験サービスのアウトソーシング動向の高まり、臨床試験の増加などによって拡大しています。しかし、適切な分析技術の開発における困難が、市場成長を抑制しています。また、慢性疾患の流行が、市場に有利な成長機会をもたらすと予測されます。

地域分析

北米が2022年に45.29%の最大の市場シェアを占め、市場規模は2030年までに約14億9,885万米ドルに達し、予測期間にCAGRで8.70%の成長が見込まれています。しかし、アジア太平洋が2030年までに11.52%の最高のCAGRを記録すると予測されます。

当レポートでは、北米、欧州、アジア太平洋の高分子バイオアナリシス試験サービス市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

• 概要
• 促進要因
  • ハイテクで信頼性の高い高分子バイオアナリシス試験サービスに対する需要の増加
  • 臨床試験サービスのアウトソーシング動向の拡大
  • バイオ医薬品部門における研究開発支出の増加
• 抑制要因
  • 適切な分析技術の開発における課題
• 機会
  • 慢性疾患の発症率の増加

第5章 市場要因の分析

• バリューチェーン分析
  • 顧客の獲得（購入前の問い合わせ）
  • サービスのカスタマイズ
  • 顧客の購入サポート
  • 顧客フルフィルメント、購入後サポート
• ポーターのファイブフォース分析モデル
• 北米、欧州、アジア太平洋の高分子バイオアナリシス試験サービス市場に対するCOVID-19の影響
  • サプライチェーンに対する影響
  • サービスプロバイダーに対する影響

第6章 北米、欧州、アジア太平洋の高分子バイオアナリシス試験サービス市場：試験タイプ別

• 概要
• 薬物動態（PK）研究
• 薬力学（PD）研究
• 生物学的同等性研究
• バイオマーカー試験
• 免疫原性試験
• その他

第7章 北米、欧州、アジア太平洋の高分子バイオアナリシス試験サービス市場：治療領域別

• 概要
• 腫瘍
• 感染症
• 循環器疾患
• 神経
• 自己免疫疾患
• その他

第8章 北米、欧州、アジア太平洋の高分子バイオアナリシス試験サービス市場：エンドユーザー別

• 概要
• 製薬企業、バイオ医薬品企業
• 受託開発製造組織（CDMO）
• 開発業務受託機関（CRO）
• 学術研究機関
• その他

第9章 北米、欧州、アジア太平洋の高分子バイオアナリシス試験サービス市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • スイス
  • オランダ
  • ベルギー
  • スウェーデン
  • ノルウェー
  • デンマーク
  • アイルランド
  • フィンランド
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • その他のアジア太平洋

第10章 競合情勢

• 概要
• 競合ベンチマーキング
• 高分子バイオアナリシスの主要企業：カテゴリ別
  • 高分子生物分析の主要企業：製薬企業別
  • 高分子生物分析の主要企業：CDMO別
  • 高分子生物分析の主要企業：CRO別
  • 高分子生物分析の主要企業：学術研究機関別
• 北米、欧州、アジア太平洋の高分子バイオアナリシス試験サービス市場における主な成長戦略
• 北米、欧州、アジア太平洋の高分子バイオアナリシス試験サービス市場における開発数の主要企業
• 主な開発分析
• 主な発展と成長戦略
  • 拡大
• 主要企業の財務状況
  • 売上（2022年）
  • 研究開発支出（2022年）

第11章 企業プロファイル

• LABORATORY CORPORATION OF AMERICA HOLDINGS
• PPD INC
• EUROFINS SCIENTIFIC
• WUXI APPTEC
• QPS HOLDINGS
• BIO-TECHNE
• ICON PLC
• CHARLES RIVER LABORATORIES
• SGS SOCIETE GENERALE DE SURVEILLANCE SA
• BIOAGILYTIX LABS
• SMITHERS
• MESO SCALE DIAGNOSTICS, LLC
• CMIC HOLDINGS CO., LTD

第12章 参考材料

LIST OF TABLES

• TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 20
• TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23
• TABLE 3 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2032 (USD MILLION) 39
• TABLE 4 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR PHARMACOKINETIC (PK) STUDIES, BY REGION 2019-2032 (USD MILLION) 40
• TABLE 5 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR PHARMACODYNAMIC (PD) STUDIES, BY REGION 2019-2032 (USD MILLION) 41
• TABLE 6 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR BIOEQUIVALENCE STUDIES, BY REGION 2019-2032 (USD MILLION) 41
• TABLE 7 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR BIOMARKER TESTING, BY REGION 2019-2032 (USD MILLION) 42
• TABLE 8 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR IMMUNOGENICITY TESTING, BY REGION 2019-2032 (USD MILLION) 42
• TABLE 9 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR OTHERS, BY REGION 2019-2032 (USD MILLION) 43
• TABLE 10 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD MILLION) 45
• TABLE 11 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR ONCOLOGY, BY REGION 2019-2032 (USD MILLION) 46
• TABLE 12 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR INFECTIOUS DISEASES, BY REGION 2019-2032 (USD MILLION) 47
• TABLE 13 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR CARDIOVASCULAR DISEASE, BY REGION 2019-2032(USD MILLION) 47
• TABLE 14 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR NEUROLOGY, BY REGION 2019-2032(USD MILLION) 47
• TABLE 15 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR AUTOIMMUNE DISORDERS, BY REGION 2019-2032(USD MILLION) 48
• TABLE 16 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR OTHERS, BY REGION 2019-2032(USD MILLION) 48
• TABLE 17 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY END USER, 2019-2032(USD MILLION) 50
• TABLE 18 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION 2019-2032 (USD MILLION) 51
• TABLE 19 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS), BY REGION 2019-2032 (USD MILLION) 52
• TABLE 20 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION 2019-2032 (USD MILLION) 52
• TABLE 21 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION 2019-2032 (USD MILLION) 53
• TABLE 22 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, FOR OTHERS, BY REGION 2019-2032 (USD MILLION) 53
• TABLE 23 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2019-2030 (USD MILLION) 55
• TABLE 24 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 56
• TABLE 25 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 56
• TABLE 26 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 57
• TABLE 27 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 59
• TABLE 28 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 60
• TABLE 29 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 60
• TABLE 30 NORTH AMERICA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 61
• TABLE 31 US LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 61
• TABLE 32 US LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 62
• TABLE 33 US LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 62
• TABLE 34 CANADA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 63
• TABLE 35 CANADA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 63
• TABLE 36 CANADA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 64
• TABLE 37 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 67
• TABLE 38 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 68
• TABLE 39 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 68
• TABLE 40 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 69
• TABLE 41 GERMANY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 69
• TABLE 42 GERMANY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 70
• TABLE 43 GERMANY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 70
• TABLE 44 FRANCE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 71
• TABLE 45 FRANCE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 71
• TABLE 46 FRANCE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 72
• TABLE 47 UK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 72
• TABLE 48 UK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 73
• TABLE 49 UK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 73
• TABLE 50 ITALY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 74
• TABLE 51 ITALY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 74
• TABLE 52 ITALY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 75
• TABLE 53 SPAIN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 75
• TABLE 54 SPAIN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 76
• TABLE 55 SPAIN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 76
• TABLE 56 SWITZERLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 77
• TABLE 57 SWITZERLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 77
• TABLE 58 SWITZERLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 78
• TABLE 59 NETHERLANDS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 78
• TABLE 60 NETHERLANDS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 79
• TABLE 61 NETHERLANDS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 79
• TABLE 62 BELGIUM: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 80
• TABLE 63 BELGIUM: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 80
• TABLE 64 BELGIUM: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 81
• TABLE 65 SWEDEN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 81
• TABLE 66 SWEDEN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 82
• TABLE 67 SWEDEN: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 82
• TABLE 68 NORWAY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 83
• TABLE 69 NORWAY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 83
• TABLE 70 NORWAY: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 84
• TABLE 71 DENMARK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 84
• TABLE 72 DENMARK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 85
• TABLE 73 DENMARK: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 85
• TABLE 74 IRELAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 86
• TABLE 75 IRELAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 86
• TABLE 76 IRELAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 87
• TABLE 77 FINLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 87
• TABLE 78 FINLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 88
• TABLE 79 FINLAND: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 88
• TABLE 80 REST OF EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 89
• TABLE 81 REST OF EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 89
• TABLE 82 REST OF EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET BY END USER, 2019-2030 (USD MILLION) 90
• TABLE 83 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2019-2030 (USD MILLION) 93
• TABLE 84 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 93
• TABLE 85 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 94
• TABLE 86 ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 94
• TABLE 87 CHINA 95
• TABLE 88 CHINA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 95
• TABLE 89 CHINA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 96
• TABLE 90 INDIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 96
• TABLE 91 INDIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 97
• TABLE 92 INDIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 97
• TABLE 93 JAPAN LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 98
• TABLE 94 JAPAN LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 98
• TABLE 95 JAPAN LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 99
• TABLE 96 SOUTH KOREA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 99
• TABLE 97 SOUTH KOREA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 100
• TABLE 98 SOUTH KOREA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 100
• TABLE 99 AUSTRALIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 101
• TABLE 100 AUSTRALIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 101
• TABLE 101 AUSTRALIA LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 102
• TABLE 102 REST OF ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE, 2019-2030 (USD MILLION) 102
• TABLE 103 REST OF ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION) 103
• TABLE 104 REST OF ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2019-2030 (USD MILLION) 103
• TABLE 105 MAJOR PLAYERS IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 105
• TABLE 106 TOP 10 PHARMA COMPANIES FOR LARGE MOLECULE BIOANALYSIS 106
• TABLE 107 TOP 10 CDMO COMPANIES FOR LARGE MOLECULE BIOANALYSIS 107
• TABLE 108 TOP 10 CRO COMPANIES FOR LARGE MOLECULE BIOANALYSIS 107
• TABLE 109 TOP 10 ACADEMIC AND RESEARCH INSTITUTIONS FOR LARGE MOLECULE BIOANALYSIS 108
• TABLE 110 MOST ACTIVE PLAYER IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 109
• TABLE 111 EXPANSION 110
• TABLE 112 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED 113
• TABLE 113 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY DEVELOPMENTS 114
• TABLE 114 PPD INC: SERVICES OFFERED 115
• TABLE 115 PPD INC: KEY DEVELOPMENTS 115
• TABLE 116 EUROFINS SCIENTIFIC: SERVICES OFFERED 118
• TABLE 117 WUXI APPTEC: SERVICES OFFERED 122
• TABLE 118 QPS HOLDINGS: SERVICES OFFERED 123
• TABLE 119 QPS HOLDINGS: KEY DEVELOPMENTS 123
• TABLE 120 BIOTECHNE: SERVICES OFFERED 126
• TABLE 121 ICON PLC: SERVICES OFFERED 129
• TABLE 122 CHARLES RIVER LABORATORIES: SERVICES OFFERED 133
• TABLE 123 SGS SOCIETE GENRALE DE SURVEILLANCE SA: PRODUCTS/SERVICES OFFERED 136
• TABLE 124 BIOAGILYTIX LABS: SERVICES OFFERED 137
• TABLE 125 SMITHERS: SERVICES OFFERED 138
• TABLE 126 MESO SCALE DIAGNOSTIC, LLC: SERVICES OFFERED 139
• TABLE 127 CMIC HOLDINGS CO., LTD: SERVICES OFFERED 141  

LIST OF FIGURES

• FIGURE 1 MARKET SYNOPSIS 18
• FIGURE 2 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 20
• FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 26
• FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 29
• FIGURE 5 DRIVER IMPACT ANALYSIS 31
• FIGURE 6 RESTRAINT IMPACT ANALYSIS 32
• FIGURE 7 VALUE CHAIN ANALYSIS: NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 33
• FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 35
• FIGURE 9 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, TEST TYPE, SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 38
• FIGURE 10 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE, 2022 & 2032 (USD MILLION) 39
• FIGURE 11 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY TEST TYPE, 2022 (%) 40
• FIGURE 12 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, THERAPEUTIC AREA, SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 44
• FIGURE 13 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY THERAPEUTIC AREA, 2022 & 2032 (USD MILLION) 45
• FIGURE 14 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY THERAPEUTIC AREA, 2022 (%) 46
• FIGURE 15 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2032 (USD MILLION) 49
• FIGURE 16 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY END USER, 2022 & 2032 (USD MILLION) 50
• FIGURE 17 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY END USER, 2022 (%) 51
• FIGURE 18 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2022 & 2030 (USD MILLION) 54
• FIGURE 19 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET SHARE, BY REGION, 2022 (% SHARE) 55
• FIGURE 20 NORTH AMERICA MARKET ANALYSIS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, 2019-2030 (USD MILLION) 58
• FIGURE 21 NORTH AMERICA: LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 59
• FIGURE 22 NORTH AMERICA: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY REGION, 2022 (% SHARE) 59
• FIGURE 23 EUROPE MARKET ANALYSIS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, 2019-2030 (USD MILLION) 65
• FIGURE 24 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 66
• FIGURE 25 EUROPE: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE (%), BY COUNTRY, 2022 67
• FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, 2019-2030 (USD MILLION) 91
• FIGURE 27 ASIA-PACIFIC: LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION) 92
• FIGURE 28 ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 92
• FIGURE 29 BENCHMARKING OF MAJOR COMPETITORS 106
• FIGURE 30 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET 108
• FIGURE 31 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET: COMPETITIVE LANDSCAPE 110
• FIGURE 32 MAJOR PLAYERS SALES (USD MILLION), 2022 111
• FIGURE 33 MAJOR PLAYER R&D EXPENDITURE (USD MILLION), 2022 111
• FIGURE 34 LABORATORY CORPORATION OF AMERICA HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT 113
• FIGURE 35 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS 114
• FIGURE 36 PPD INC: SWOT ANALYSIS 116
• FIGURE 37 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 118
• FIGURE 38 EUROFINS SCIENTIFIC: SWOT ANALYSIS 119
• FIGURE 39 WUXI APPTEC: FINANCIAL OVERVIEW SNAPSHOT 121
• FIGURE 40 BIOTECHNE: FINANCIAL OVERVIEW SNAPSHOT 126
• FIGURE 41 ICON PLC: FINANCIAL OVERVIEW SNAPSHOT 129
• FIGURE 42 ICON PLC: SWOT ANALYSIS 130
• FIGURE 43 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT 132
• FIGURE 44 CHARLES RIVER LABORATORIES: SWOT ANALYSIS 134
• FIGURE 45 SGS SOCIETE GENRALE DE SURVEILLANCE SA: FINANCIAL OVERVIEW SNAPSHOT 135
• FIGURE 46 CMIC HOLDINGS CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 140  

Market Overview

The market for large molecule bioanalysis testing services in North America, Europe, and Asia-Pacific is expanding due to rising demand for high-tech and dependable large molecule bioanalytical testing services, a growing trend of outsourcing laboratory testing services, and an increase in the number of clinical trials. However, the difficulties in developing appropriate analytical techniques are limiting the growth of the North America, Europe, and Asia-Pacific large molecule bioanalysis testing services market. Furthermore, the growing prevalence of chronic diseases is expected to provide lucrative growth opportunities for the North America, Europe, and Asia-Pacific large molecule bioanalysis testing services market.

The concentration of large molecules in biological samples such as proteins and antibodies are determined using large molecule bioanalytical testing services. Large molecules are frequently utilized in drug development, and bioanalytical testing is required to ensure these drugs' safety and efficacy.

The expected growth in market can be attributed to the increasing demand for high-tech and reliable large molecule bioanalytical testing services, growing trend of outsourcing laboratory testing services, and rising R&D expenditure in the biopharmaceutical sector. However, the market is also held back by challenges in the development of proper analytical techniques. Nevertheless, it is anticipated that the growing incidence of chronic diseases will create lucrative opportunities for the players operating in the North America, Europe, And Asia-Pacific large molecule bioanalysis testing services market.

MARKET SEGMENTATION

Based on test type, the large molecule bioanalysis testing market has been segmented into pharmacokinetic (PK) studies, pharmacodynamic studies, bioequivalence studies, immunogenicity testing, biomarker testing and others.

Based on therapeutic area, the market has been segmented into oncology, infectious diseases, cardiovascular diseases, neurology, autoimmune disorders, and others.

Based on test type, the market has been segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), academic and research institutes, and others.

Regional Analysis

Based on region, the large molecule bioanalysis testing services market has been segmented into North America, Europe, and Asia-Pacific. North America accounted for the largest market share of 45.29% in 2022 and is anticipated to reach approximately USD 1,498.85 million by 2030 at an 8.70% CAGR during the forecast period. However, Asia-Pacific is projected to register the highest CAGR of 11.52% by 2030.

MAJOR PLAYERS

America Holdings (US), ICON plc (Ireland), SGS Societe Generale de Surveillance SA (Switzerland), WuXi AppTec (China), Charles River Laboratories (US), Eurofins Scientific (luxembourg), QPS Holdings (US), BioTechne (US), PPD, Inc (US), BioAgilytix Labs (US), Smithers (US), Meso Scale Diagnostic, LLC (US), and CMIC HOLDINGS CO., LTD (Japan).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 INCREASING DEMAND FOR HIGH-TECH AND RELIABLE LARGE MOLECULE BIOANALYTICAL TESTING SERVICES
  • 4.2.2 GROWING TREND OF OUTSOURCING LABORATORY TESTING SERVICES
  • 4.2.3 RISING R&D EXPENDITURE IN THE BIOPHARMACEUTICAL SECTOR
• 4.3 RESTRAINTS
  • 4.3.1 CHALLENGES IN THE DEVELOPMENT OF PROPER ANALYTICAL TECHNIQUES
• 4.4 OPPORTUNITIES
  • 4.4.1 GROWING INCIDENCE OF CHRONIC DISEASES

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 CUSTOMER ACQUISITION (PRE-PURCHASE QUERY)
  • 5.1.2 SERVICE CUSTOMIZATION
  • 5.1.3 CUSTOMER PURCHASE SUPPORT
  • 5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON SERVICE PROVIDER

6 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY TEST TYPE

• 6.1 OVERVIEW
• 6.2 PHARMACOKINETIC (PK) STUDIES
• 6.3 PHARMACODYNAMIC (PD) STUDIES
• 6.4 BIOEQUIVALENCE STUDIES
• 6.5 BIOMARKER TESTING
• 6.6 IMMUNOGENICITY TESTING
• 6.7 OTHERS

7 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY THERAPEUTIC AREA

• 7.1 OVERVIEW
• 7.2 ONCOLOGY
• 7.3 INFECTIOUS DISEASES
• 7.4 CARDIOVASCULAR DISEASE
• 7.5 NEUROLOGY
• 7.6 AUTOIMMUNE DISORDERS
• 7.7 OTHERS

8 NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
• 8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS)
• 8.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
• 8.5 ACADEMIC AND RESEARCH INSTITUTES
• 8.6 OTHERS

9 NORTH AMERICA, EUROPE, ASIA-PACIFIC LARGE MOLECULE BIOANALYTICAL TESTING SERVICES MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 SWITZERLAND
  • 9.3.7 NETHERLANDS
  • 9.3.8 BELGIUM
  • 9.3.9 SWEDEN
  • 9.3.10 NORWAY
  • 9.3.11 DENMARK
  • 9.3.12 IRELAND
  • 9.3.13 FINLAND
  • 9.3.14 REST OF EUROPE
• 9.4 ASIA-PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 SOUTH KOREA
  • 9.4.5 AUSTRALIA
  • 9.4.6 REST OF ASIA-PACIFIC

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY CATEGORY
  • 10.3.1 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY PHARMA
  • 10.3.2 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY CDMO
  • 10.3.3 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY CRO
  • 10.3.4 TOP COMPANIES FOR LARGE MOLECULE BIOANALYSIS, BY ACADEMIC AND RESEARCH INSTITUTIONS
• 10.4 MAJOR GROWTH STRATEGY IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET
• 10.5 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE NORTH AMERICA, EUROPE, AND ASIA-PACIFIC LARGE MOLECULE BIOANALYSIS TESTING SERVICES MARKET
• 10.6 KEY DEVELOPMENT ANALYSIS
• 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.7.1 EXPANSION
• 10.8 MAJOR PLAYERS FINANCIAL
  • 10.8.1 SALES (USD MILLION), 2022
  • 10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

• 11.1 LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 SERVICES OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 PPD INC
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 SERVICES OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 EUROFINS SCIENTIFIC
  • 11.3.1 COMPANY OVERVIEWS
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 SERVICES OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 WUXI APPTEC
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 SERVICES OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 KEY STRATEGIES
• 11.5 QPS HOLDINGS
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 SERVICES OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 KEY STRATEGIES
• 11.6 BIO-TECHNE
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 SERVICES OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 KEY STRATEGIES
• 11.7 ICON PLC
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 SERVICES OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 SWOT ANALYSIS
  • 11.7.6 KEY STRATEGIES
• 11.8 CHARLES RIVER LABORATORIES
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 SERVICES OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 SGS SOCIETE GENERALE DE SURVEILLANCE SA
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS/SERVICES OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 BIOAGILYTIX LABS
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 SERVICES OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES
• 11.11 SMITHERS
  • 11.11.1 COMPANY OVERVIEW
  • 11.11.2 FINANCIAL ANALYSIS
  • 11.11.3 SERVICES OFFERED
  • 11.11.4 KEY DEVELOPMENTS
  • 11.11.5 KEY STRATEGIES
• 11.12 MESO SCALE DIAGNOSTICS, LLC
  • 11.12.1 COMPANY OVERVIEW
  • 11.12.2 FINANCIAL ANALYSIS
  • 11.12.3 SERVICES OFFERED
  • 11.12.4 KEY DEVELOPMENTS
  • 11.12.5 KEY STRATEGIES
• 11.13 CMIC HOLDINGS CO., LTD
  • 11.13.1 COMPANY OVERVIEW
  • 11.13.2 FINANCIAL OVERVIEW
  • 11.13.3 SERVICES OFFERED
  • 11.13.4 KEY DEVELOPMENTS
  • 11.13.5 KEY STRATEGIES

12 REFERENCES

• 12.1 RELATED REPORTS